Renal denervation is an emerging, guideline-supported therapeutic option for resistant hypertension that requires rigorous patient selection and experienced centers.
RDN represents an emerging therapeutic option for RH, now recommended by European societies for specific indications. Rigorous patient selection and performance in experienced centers remain essential.
Cordeanu et al. (Thu,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: